We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.55 | 4.30 | 4.80 | 4.55 | 4.55 | 4.55 | 496,424 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.83 | 24.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/5/2019 13:47 | Not sure you will get a reply, I wrote a couple of weeks back asking if there was some sort of strategy in place to capitalise on this current anti pesticide press... and no response as yet.. | bjlk | |
30/5/2019 13:37 | sean@edenresearch.co | supersonico | |
30/5/2019 12:59 | dplewis1..Two guesses; 1)We are in the Dampening part of the cycle. A purchase by Lykele risks tipping that which would be problematic if a further strategic investor is planned. 2)Lykele is a Bayer linkman and as such holds privileged information which makes him an insider. He expected a short ordered Parallel delay but something kicked those conjoined cans further down the road. | supersonico | |
30/5/2019 12:47 | Regretting my decision to reinvest here.. Does anyone know why this Lykele bloke doesn't own any shares? | dplewis1 | |
30/5/2019 12:20 | Investing, a brilliant post..I really think Eden should read, inwardly digest and come up with a strategy to fulfil their complete job descriptions ...Definitely the massive jam tomorrow question but now well past sell by date..Share options expiring doesn't seem to light the fuse either.. I'm at a loss as to what will ignite some urgency with our short order management.. | bjlk | |
30/5/2019 11:34 | good spot super | attyg | |
30/5/2019 11:02 | Eden Research plc@edenresearch The 2019 season in Italy closely resembles 2013 - repeated rains and cold temperatures in spring - leading to high risk of fungal diseases such as #botrytis. Preventative spray programmes are essential. | supersonico | |
30/5/2019 08:42 | I know a number of people are really fed up with the ongoing lack of value being reflected in the share price. I certainly am. How long, even in a regulatory framework, can one continue with the mantra that these things take time, especially when we have two commercial products, delivered via Sustaine, with Sustaine (we assume, not unreasonably) having successful trials elsewhere with Agrochemical majors and full confirmations still to come alongside commercial arrangements. Mevalone is now a global product as a result of Sipcam's uptake right's. It is, we are told, being used now as a pre-harvest, 'protector'/'insurer This is before we even address Cedroz which has a bigger impact, plus the awaited new products in bigger markets. You can take a definition from wherever you want, I've taken the easiest to find. "The chief executive officer (CEO)[1] or just chief executive (CE), is the most senior corporate, executive, or administrative officer in charge of managing an organization – especially an independent legal entity such as a company or nonprofit institution. CEOs lead a range of organizations, including public and private corporations, non-profit organizations and even some government organizations (e.g., Crown corporations). The CEO of a corporation or company typically reports to the board of directors and is charged with maximizing the value of the entity,[1] which may include maximizing the share price, market share, revenues or another element. In the non-profit and government sector, CEOs typically aim at achieving outcomes related to the organization's mission, such as reducing poverty, increasing literacy, etc. In the early 21st century, top executives typically had technical degrees in science, engineering or law.[2]" From above "The CEO of a corporation or company typically reports to the board of directors and is charged with maximizing the value of the entity,[1] which may include maximizing the share price" I have no issue with Sean's online delivery, nor his connections, nor his IP knowledge and background. I have no basis to, I doubt anyone does. However, he is not maximising the share price. It cannot be argued one day Rodney, when so many days have passed with the result of the above products, relationships and technology. And we have a former high ranking employee of Bayer as our Chairman which doesn't on the face of it after 18 months in situ, appear to be delivering anything of value that we as shareholders can measure. That is fair observation. A CEO has to deliver share price value and that has to be on an ongoing basis, trending upwards and in line with business performance + forward prospects, traditionally measured on a three year timeline. Eden has nothing factored in for the latter and much of its business achievement thus far not factored in to today's share price. It is illogical and unrealistic to expect that one moment in time, yet to come, will catapult the share price north and vertical in an instant and correct all share price performance woes to-date. That if it ever happened, would lead to a mass sell out and a decline in the share price as quick as the incline that occurred. The CEO of Eden has to maximise the share price now and this is an ongoing role and responsibility. it isn't to be implemented when you wish to. It is an ongoing process. NDA's, partners et al do not have the power to supress another's share price and it is unthinkable to imagine this can be so. I know the BoD will read this and other posts and I know they will know who wrote this. I have no ill will towards the BoD, but our CEO whoever that may be an any point in time has to do their utmost to ensure that the share price of today and every day reflects the true value of the Company today. If they truly believe our share price and market cap is fair value right now, then do nothing at circa £23 million. If however this is not what they believe and know value to be, then they need to act to move the share price and show their audience true reasons why the share price should be much higher and therefore why people should invest in it today. This 'moan' by many is not going to go away until it is dealt with. Institutions are not and do not buy into Eden at this level. So they truly have no options but to stir up the market and in due course the hoped for institutions might come on board. Is our current CEO going to be the CEO to put value into the share price today based on current achievements or is another going to be brought into the business to deliver that value today, as well as the ongoing process of creating value for the future, the latter of which I am sure Sean is seeking to achieve. | investingisatrickygame | |
29/5/2019 13:09 | Again, no more 5 a day then. Too dangerous! | investingisatrickygame | |
29/5/2019 12:02 | Looking forward to reading the Farage / Banks /Trump.. Kill em All.. Food and Farming Manifesto. Pesticides explained: the toxic chemicals in up to 70% of produce Studies have linked long-term health issues, while regulators insist breaches of safe limits are rare ……&hel ..//////// BASF collaborates with Rothamsted Research on sustainable agriculture...&helli | supersonico | |
28/5/2019 09:25 | Eden Research plc@edenresearch Eden Research plc Retweeted NematodeFacts #Cedroz is an innovative new nematicide which targets root knot #nematodes. Eden's encapsulation technology enables #terpenes to be used as an effective, sustainable solution and a valuable part of #IPM. | supersonico | |
24/5/2019 13:05 | Perhaps the Field Crops Trails Cotton/Soybean/Wheat and the IPM note were related?? 2019 Insect Control Recommendations for Field Crops Cotton, Soybean, Field Corn, Sorghum, Wheat and Pasture ……&hel | supersonico | |
24/5/2019 07:07 | Qian Xuhong @ECNUER IUPAC 2019@iupac2019 ‘20 years ago, you would hear terrible stories of chinese farmers hurt by highly #toxic pesticides. Now thanks to societal #progress #China has innovating green #pesticides’ says Qian Xuhong @ECNUER on the sofa with @FemiOke̽ IUPAC 2019@iupac2019 "A lot of effort and resources are invested in China to develop novel and greener #cropprotection products", says Qian Xuhong @ECNUER #iupacNextGen We have about 2000 #cropprotection companies in China, but due to stricter regulation there will be a lot of consolidation in the market and only about 1 to 10% will likely survive", says Qian Xuhong: @ECNUER #iupacNextGen ……&hel Eulogy for the end of the 'Green revolution'. David Zaruk ‘The experts are no longer considered valid, we can’t trust risk assessment anymore, citizen panels will decide whether something can be used or not’ A scary thought @zaruk #blockchain #iupacNextGen #cropprotection | supersonico | |
23/5/2019 15:20 | I love it when non scientists talk about science based evidence. | chrischas | |
23/5/2019 07:58 | While Bayer still peddle the 'public don't understand' narrative. Despite all the evidence that's come out in the 'discovery' process during the Round up Trials. Are the audience really that ignorant of the trial details?and Monsanto's criminality ? IUPAC 2019@iupac2019 "To better understand the difference between #risk & #exposure, I always explain that if 1 ng of #glyphosate would be found in a1glass of wine, it would still contain 130 million times as much alcohol, which is a proven carcinogenic": @marc_sneyders @Bayer4CropsBE #iupacNextGen What planet are you on V_Andriukaitis ? Monsanto corrupted the 'science' ..that's why they had to ghost write everything . This is common knowledge now. Speaking at @IUPACNextGen @V_Andriukaitis shares his concern that the stated preference of some #spitzenkandidat for banning glyphosate may spell the end of evidence and science based decision making - Should be a concern for every1 @cropprotection #WithOrWithout #ECPAConf2019 ……&hel Michal Kicinski@Michal_Kici EU Commissioner @V_Andriukaitis underlines the importance of #science and risk communication concerning the approval and use of #pesticides. If we follow public opinion instead of a science based system we will never have food safety in the EU #WithOrWithout #iupacNextGen. ……&hel IUPAC 2019@iupac2019 "Scientists should not talk to everyone. The biggest opportunity for science communication lays in the middle and not at the extremes of public opinion! We better focus our energy and attention", says @achood4mu from @Bayer4Crops #iupacNextGen ……&hel | supersonico | |
23/5/2019 02:11 | I'm in the US at the moment and was just watching some TV and an ad came on by a claims firm doing a 'PPI' style no-win-no-fee for anyone who thinks they may have cancer from glyphosate. The whole thing had a huge 'probable human carcinogen' banner and all sorts of wild claims for how much you would get paid out. In the absence of any news from Eden, at least glyphosate is continuing to gather a bad rep.. | dplewis1 | |
22/5/2019 20:44 | Duke Biopesticides: State of the Art and future opportunities. ……&hel New Pesticide Modes of Action from Natural Products agrithority.com/wp/w Page 18 ..Mode of Action chart Insecticide. The mode of action describes how the pesticide kills or inactivates a pest. It provides another way of classifying insecticides. Mode of action is important in understanding whether an insecticide will be toxic to unrelated species, such as fish, birds and mammals | supersonico | |
22/5/2019 15:36 | Dont worry folks the Terpenetec investment will come good I'm sure pmsl | quazie12 | |
22/5/2019 13:27 | Will Do ..Wrongly assumed you had these figures to hand. | supersonico | |
22/5/2019 12:43 | Check the accounts! | investingisatrickygame | |
22/5/2019 11:18 | Moderator at IUPAC 2019 looks confused as Sir Fraser Stoddart, Noble prize winner in Chemistry tries to explain Edens Shares price. | supersonico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions